X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-02-12 | NFRX | 2023 Etf Series Trust | Harrison Street Real Assets Fund LLC | 10% | P - Purchase | $26.93 | +1,485,332 | 3,822,021 | +64% | +$39,999,991 | ||||||
2026-02-13 | NDAQ | Nasdaq, Inc. | Investor Ab | 10% | P - Purchase | $79.18 | +200,000 | 58,382,426 | 0% | +$15,835,040 | ||||||
2026-02-11 | PSEC | Prospect Capital Corp | Eliasek M Grier | COO | P - Purchase | $2.92 | +942,800 | 3,443,930 | +38% | +$2,749,770 | ||||||
| M | 2026-02-11 | DMLP | Dorchester Minerals, L.P. | Dorchester Minerals Operating LP | Entity Under Common Control | P - Purchase | $25.24 | +20,000 | 55,017 | +57% | +$504,750 | |||||
| M | 2026-02-11 | SRZN | Surrozen, Inc./De | Tcg Crossover Gp Ii, LLC | 10% | P - Purchase | $23.59 | +18,856 | 651,112 | +3% | +$444,844 | |||||
| M | 2026-02-11 | NRX | Neuraxis, Inc | Hannasch Brian | 10% | P - Purchase | $4.79 | +80,000 | 1,211,522 | +7% | +$382,800 | |||||
2026-02-13 | QDEL | Quidelortho Corp | Blaser Brian J. | Pres, CEO | P - Purchase | $23.59 | +10,540 | 65,215 | +19% | +$248,661 | ||||||
2026-02-13 | QDEL | Quidelortho Corp | Strobeck Matthew | Dir | P - Purchase | $23.96 | +10,000 | 82,550 | +14% | +$239,586 | ||||||
2026-02-13 | CLF | Cleveland-Cliffs Inc. | Camara Edilson | Dir | P - Purchase | $10.13 | +19,700 | 41,983 | +88% | +$199,626 | ||||||
2026-02-11 | CINF | Cincinnati Financial Corp | Debbink Dirk J | Dir | P - Purchase | $162.58 | +1,000 | 60,560 | +2% | +$162,580 | ||||||
2026-02-12 | COSM | Cosmos Health Inc. | Siokas Grigorios | CEO, 10% | P - Purchase | $0.37 | +388,532 | 8,861,914 | +5% | +$145,000 | ||||||
2026-02-12 | AXR | Amrep Corp. | Dahl James H | 10% | P - Purchase | $23.71 | +4,358 | 945,077 | 0% | +$103,315 | ||||||
2026-02-13 | CMTV | Community Bancorp /Vt | Marvin Emma | Dir | P - Purchase | $32.50 | +3,100 | 9,648 | +47% | +$100,750 | ||||||
2026-02-12 | TENB | Tenable Holdings, Inc. | Vicks Raymond Jr. | Dir | P - Purchase | $22.17 | +4,500 | 20,766 | +28% | +$99,765 | ||||||
2026-02-12 | LUCK | Lucky Strike Entertainment Corp | Harinstein Jason | Dir | P - Purchase | $7.54 | +13,000 | 13,000 | New | +$98,020 | ||||||
2026-02-12 | PNFP | Pinnacle Financial Partners, Inc. | Gregory Andrew J. Jr. | CFO | P - Purchase | $94.52 | +1,000 | 49,485 | +2% | +$94,520 | ||||||
| M | 2026-02-11 | ONCY | Oncolytics Biotech Inc | Seizinger Bernd R. | Dir | P - Purchase | $0.83 | +100,000 | 566,991 | +21% | +$83,454 | |||||
2026-02-13 | QDEL | Quidelortho Corp | Busky Joseph M. | CFO | P - Purchase | $23.66 | +3,370 | 51,702 | +7% | +$79,742 | ||||||
2026-02-12 | BWFG | Bankwell Financial Group, Inc. | Seidman Lawrence B | Dir | P - Purchase | $48.11 | +1,600 | 792,128 | 0% | +$76,982 | ||||||
| M | 2026-02-10 | RBBN | Ribbon Communications Inc. | McClelland Bruce William | Pres, CEO | P - Purchase | $2.01 | +37,000 | 1,516,164 | +3% | +$74,307 | |||||
2026-02-12 | WTW | Willis Towers Watson Plc | Hammond Michael P. | Dir | P - Purchase | $278.86 | +241 | 2,505 | +11% | +$67,205 | ||||||
2026-02-12 | ONCY | Oncolytics Biotech Inc | Andrews Patricia S | Dir | P - Purchase | $0.86 | +35,400 | 78,128 | +83% | +$30,292 | ||||||
| M | 2026-02-11 | ONCY | Oncolytics Biotech Inc | Kelly Jared | CEO | P - Purchase | $0.84 | +35,100 | 109,000 | +47% | +$29,521 | |||||
2026-02-11 | ONCY | Oncolytics Biotech Inc | Aromando Andrew | Chief Business Officer | P - Purchase | $0.86 | +29,600 | 55,100 | +116% | +$25,418 | ||||||
2026-02-12 | ONCY | Oncolytics Biotech Inc | Pisano Wayne | Dir | P - Purchase | $0.84 | +30,000 | 492,414 | +6% | +$25,338 | ||||||
2026-02-12 | ONCY | Oncolytics Biotech Inc | Brown Deborah Margaret | Dir | P - Purchase | $0.85 | +25,000 | 109,851 | +29% | +$21,240 | ||||||
2026-02-12 | NAIFX | Nomura Alternative Income Fund | Rosa Katherine Quick | Trustee | P - Purchase | $9.79 | +1,404 | 6,641 | +27% | +$13,750 | ||||||
2026-02-12 | ONCY | Oncolytics Biotech Inc | Look Kirk | CFO | P - Purchase | $0.84 | +12,000 | 287,515 | +4% | +$10,104 | ||||||
2026-02-12 | ONCY | Oncolytics Biotech Inc | Heineman Thomas Charles | Chief Medical Officer | P - Purchase | $0.83 | +12,132 | 282,818 | +4% | +$10,033 | ||||||
2026-02-12 | ONCY | Oncolytics Biotech Inc | Hagerman Allison | VP, Product Development | P - Purchase | $0.83 | +10,000 | 115,059 | +10% | +$8,298 | ||||||
2026-02-12 | RCG | Renn Fund, Inc. | Stahl Murray | Pres, Co-Portfolio Manager, 10% | P - Purchase | $2.73 | +1,134 | 1,035,838 | 0% | +$3,096 | ||||||
2026-02-13 | OVBC | Ohio Valley Banc Corp | Michael Seth Isaac | Dir | P - Purchase | $42.81 | +69 | 689 | +11% | +$2,970 | ||||||
2026-02-13 | OVBC | Ohio Valley Banc Corp | Barnitz Anna P | Dir | P - Purchase | $42.81 | +35 | 9,025 | 0% | +$1,485 | ||||||
2026-02-12 | TPL | Texas Pacific Land Corp | Horizon Kinetics Asset Management LLC | 10% | P - Purchase | $413.24 | +1 | 3,479,372 | 0% | +$413 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |